T1	Intervention 786 916	randomised between treatment with capecitabine, oxaliplatin and bevacizumab or the same combination with the addition of cetuximab
T2	Intervention 973 1106	patients in the Ca/Mg(+) group received Ca/Mg at least during their first treatment cycle, and patients in the Ca/Mg(-) group did not
